9801:HK:HK-iShares Core MSCI China ETF (GBP)

ETF | Others |

Last Closing

USD 2.252

Change

+0.04 (+1.72)%

Market Cap

N/A

Volume

4.57K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.25 (+1.37%)

USD 122.96B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+1.12 (+1.72%)

USD 21.03B
2823:HK iShares FTSE A50 China

+0.15 (+1.15%)

USD 13.92B
83188:HK ChinaAMC CSI 300 Index ETF

+0.22 (+0.59%)

USD 13.48B
2801:HK iShares Core MSCI China ETF

+0.36 (+1.91%)

USD 9.42B
9067:HK iShares Hang Seng TECH ETF

+0.03 (+2.69%)

USD 9.25B
3067:HK iShares Hang Seng TECH ETF

+0.22 (+2.71%)

USD 9.25B
82822:HK CSOP FTSE China A50

+0.06 (+0.53%)

USD 7.86B
3010:HK iShares MSCI AC Asia ex Japan

+0.38 (+0.73%)

USD 3.15B

ETFs Containing 9801:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.09% 61% D- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.09% 61% D- 65% D
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBP)

Quarterly Financials (GBP)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike